Invent Medic has received notice of allowance for a patent application in the USA related to the company’s product Efemia bladder support. The patent will be valid until 2039.
The patent application (17/046,706) describes the current version of Efemia bladder support, including developments made of the product following the first patent (which is already approved in the USA) while delivering the same effect. Today’s announcement therefore constitutes an important strengthening of Efemia bladder support’s patent protection in one of the company’s most important markets.
“This strengthening of our patent protection for Efemia bladder support in the USA is positive for our ongoing process to establish the company in this market. Among other things, it contributes to a more favourable position when we proceed from talks to negotiations with potential business partners in the USA,” says Invent Medic’s CEO Karin Bryder.
When issuing a notice of allowance, the patent office has the intention to grant the patent application following the final steps of the procedure, such as payment of the patent fee.